The impact of eculizumab on routine complement assays.
Willrich MAV, Andreguetto BD, Sridharan M, Fervenza FC, Tostrud LJ, Ladwig PM, Rivard AM, Hetrick MD, Olson RN, Bryant SC, Snyder MR, Murray DL.
Willrich MAV, et al. Among authors: tostrud lj.
J Immunol Methods. 2018 Sep;460:63-71. doi: 10.1016/j.jim.2018.06.010. Epub 2018 Jun 20.
J Immunol Methods. 2018.
PMID: 29935209
Clinical Trial.